AZ sells EU rights to Seloken, Logimax to Recordati by Selina McKee | May 22, 2017 | News | 0 AstraZeneca has sold European rights to its metoprolol-containing cardiovascular drugs to Italian drugmaker Recordati for $300 million. Read More